Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

99 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2023-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective study aims to assess the utility of 2D non-navigated intraoperative ultrasound (ioUS) as a cost-effective alternative for guiding the surgical resection of gliomas and for detecting residual tumor. The study will analyse the records from consecutive adult patients diagnosed with gliomas, undergoing craniotomy between June 2018 and June 2023. The extent of resection (EOR) will be determined using postoperative MRI as the gold standard. The study will also examine the sensitivity and specificity of ioUS in detecting residual tumor. This research seeks to determine if ioUS can be an affordable and reliable tool that, combined with other intraoperative adjuncts, may aid neurosurgeons in achieving the maximum safe resection in glioma surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Role of Intraoperative Ultrasound in Gross Total Resection of Gliomas

NCT05707728

Glioma

UNKNOWN

Brain Tumor Intraoperative Ultrasound Database

NCT05062772

Brain Tumor Brain Neoplasms Brain Cancer +2 more

COMPLETED

Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas

NCT03542409

Brain Tumor Adult

ACTIVE_NOT_RECRUITING NA

Intraoperative Sonographically Guided Resection of Non-enhancing Gliomas

NCT05470374

Non-enhancing Cerebral Gliomas

SUSPENDED NA

Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors

NCT03970499

Brain Tumor, Primary

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective:

The objective of this retrospective study is to evaluate the effectiveness and utility of 2D non-navigated intraoperative ultrasound (ioUS) as a cost-effective method for guiding the surgical resection of gliomas and detecting residual tumor.

Methods:

The study will retrospectively analyze the records of consecutive adult patients diagnosed with gliomas who underwent craniotomy between June 2018 and June 2023. The patients' records must show that they underwent both intraoperative ultrasound and postoperative MRI.

Evaluation Criteria:

The primary evaluation metric will be the extent of resection (EOR), which will be determined using postoperative MRI scans as the gold standard. The EOR will be classified into gross total resection (GTR), near-total resection (NTR), subtotal resection (STR), and partial resection (PR) based on the MRI scans.

The study will also examine the sensitivity and specificity of ioUS in detecting residual tumor postoperatively. This analysis will help determine the accuracy of ioUS in predicting residual tumor that may not have been apparent during the surgical procedure.

Expected Outcomes:

The study aims to determine if ioUS can be a reliable and affordable tool for guiding the surgical resection of gliomas. If successful, ioUS, in conjunction with other intraoperative adjuncts, may provide a cost-effective method to aid neurosurgeons in achieving the maximum safe resection in glioma surgery.

The results of this study could have significant implications for the management of glioma patients, potentially leading to improved surgical outcomes, decreased postoperative complications, and ultimately, improved patient survival and quality of life.

The data collected from this retrospective analysis could also provide valuable insights for future prospective studies and could contribute to the development of guidelines for the use of ioUS in neurosurgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glioma Glioma, Malignant Low-grade Glioma High-grade Glioma Glioblastoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Operated gliomas

Patients consecutively operated with a pathological diagnosis of glial tumor

intraoperative ultrasound

Intervention Type DIAGNOSTIC_TEST

Use of 2D non-navigated intraoperative ultrasound as an operative adjunct

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intraoperative ultrasound

Use of 2D non-navigated intraoperative ultrasound as an operative adjunct

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients aged 18 years or older.
* Patients diagnosed with gliomas, confirmed by a pathologist.
* Patients who are scheduled to undergo craniotomy for tumor resection.
* Patients who are willing and able to give informed consent for participation in the trial.
* Patients who are capable of undergoing both intraoperative ultrasound and postoperative MRI.

Exclusion Criteria

* Patients under the age of 18.
* Patients with non-glioma brain tumors.
* Patients who underwent stereotactic biopsies.
* Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or any other reason.
* Patients with contraindications for MRI such as certain types of implanted medical devices, severe claustrophobia, or allergies to contrast material.
* Pregnant or breastfeeding women.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No